Anthrax lethal and edema toxins (LeTx and EdTx, respectively) form by binding of lethal factor (LF) or edema factor (EF) to the pore-forming moiety protective antigen (PA). Immunity to LF and EF protects animals from anthrax spore challenge and neutralizes anthrax toxins. The goal of the present study is to identify linear B-cell epitopes of EF and to determine the relative contributions of cross-reactive antibodies of EF and LF to LeTx and EdTx neutralization. A/J mice were immunized with recombinant LF (rLF) or rEF. Pools of LF or EF immune sera were tested for reactivity to rLF or rEF by enzyme-linked immunosorbent assays, in vitro neutralization of LeTx and EdTx, and binding to solid-phase LF and EF decapeptides. Cross-reactive antibodies were isolated by column absorption of EF-binding antibodies from LF immune sera and by column absorption of LF-binding antibodies from EF immune sera. The resulting fractions were subjected to the same assays. Major cross-reactive epitopes were identified as EF amino acids (aa) 257 to 268 and LF aa 265 to 274. Whole LF and EF immune sera neutralized LeTx and EdTx, respectively. However, LF sera did not neutralize EdTx, nor did EF sera neutralize LeTx. Purified cross-reactive immunoglobulin G also failed to cross-neutralize. Cross-reactive B-cell epitopes in the PA-binding domains of whole rLF and rEF occur and have been identified; however, the major anthrax toxin-neutralizing humoral responses to these antigens are constituted by non-cross-reactive epitopes. This work increases understanding of the immunogenicity of EF and LF and offers perspective for the development of new strategies for vaccination against anthrax.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772542PMC
http://dx.doi.org/10.1128/IAI.00749-09DOI Listing

Publication Analysis

Top Keywords

letx edtx
16
immune sera
16
anthrax lethal
8
lethal edema
8
non-cross-reactive epitopes
8
b-cell epitopes
8
cross-reactive antibodies
8
column absorption
8
antibodies immune
8
edtx sera
8

Similar Publications

Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.

Toxicon

December 2017

School of studies in Zoology, Jiwaji University, Gwalior, Madhya Pradesh, 474002, India. Electronic address:

Article Synopsis
  • Anthrax in humans and animals is primarily caused by two exotoxins from the bacterium Bacillus anthracis, consisting of protective antigen (PA), lethal factor (LF), and edema factor (EF).
  • Therapeutic strategies focusing on neutralizing these exotoxins can help combat the effects of anthrax on the host.
  • The study found that antibodies developed against a specific domain of PA, known as domain IV, demonstrated strong potential in neutralizing the lethal toxin, suggesting it could be an effective therapeutic option alongside antibiotics.
View Article and Find Full Text PDF

Anthrax lethal toxin (LeTx) and edema toxin (EdTx) have been shown to alter hemodynamics in the rodent model, while LeTx primarily is reported to induce extensive tissue pathology. However, the rodent model has limitations when used for comparison to higher organisms such as humans. The rabbit model, on the other hand, has gained recognition as a useful model for studying anthrax infection and its pathophysiological effects.

View Article and Find Full Text PDF

Inhalational anthrax, a zoonotic disease caused by the inhalation of Bacillus anthracis spores, has a ∼50% fatality rate even when treated with antibiotics. Pathogenesis is dependent on the activity of two toxic noncovalent complexes: edema toxin (EdTx) and lethal toxin (LeTx). Protective antigen (PA), an essential component of both complexes, binds with high affinity to the major receptor mediating the lethality of anthrax toxin in vivo, capillary morphogenesis protein 2 (CMG2).

View Article and Find Full Text PDF

A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.

Antimicrob Agents Chemother

November 2010

State Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, Shizishan Street 1, Wuhan, People's Republic of China.

Effective measures for the prophylaxis and treatment of anthrax are still required for counteracting the threat posed by inhalation anthrax. In this study, we first demonstrated that the chimeric protein LFn-PA, created by fusing the protective antigen (PA)-binding domain of lethal factor (LFn) to PA, retained the functions of the respective molecules. On the basis of this observation, we attempted to develop an antitoxin that targets the binding of lethal factor (LF) and/or edema factor (EF) to PA and the transportation of LF/EF.

View Article and Find Full Text PDF

Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.

Toxins (Basel)

May 2010

Laboratory of Cancer and Developmental Cell Biology, The Van Andel Research Institute, 333 Bostwick NE Grand Rapids, MI, USA.

Article Synopsis
  • Anthrax is caused by the bacterium Bacillus anthracis, with its effects largely driven by two key toxins: edema toxin (EdTx) and lethal toxin (LeTx).
  • The lethal toxin (LeTx) is the main factor that makes anthrax dangerous, and it operates by targeting specific proteins in host cells that regulate cell signaling.
  • This review will explore how LeTx's lethal factor (LF) works, its role in causing anthrax disease, and how understanding LF can help researchers investigate other diseases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!